Rede Wealth, LLC - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 22 filers reported holding ADIAL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rede Wealth, LLC ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$41,000
-36.9%
15,2000.0%0.02%
-40.0%
Q3 2021$65,000
+66.7%
15,2000.0%0.04%
+66.7%
Q2 2021$39,000
+8.3%
15,200
+1.3%
0.02%0.0%
Q1 2021$36,00015,0000.02%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Manchester Capital Management LLC 1,202,452$250,3510.03%
COMMONWEALTH EQUITY SERVICES, LLC 36,461$80.00%
Creative Planning 10,000$2,0820.00%
ROYAL BANK OF CANADA 964$00.00%
VANGUARD GROUP INC 203,358$42,3390.00%
TWO SIGMA INVESTMENTS, LP 17,623$3,6690.00%
OSAIC HOLDINGS, INC. 24,046$4,9980.00%
WELLS FARGO & COMPANY/MN 187$390.00%
NORTHERN TRUST CORP 29,705$6,1850.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders